These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26617219)

  • 1. Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials.
    Van Acker HH; Anguille S; Willemen Y; Smits EL; Van Tendeloo VF
    Pharmacol Ther; 2016 Feb; 158():24-40. PubMed ID: 26617219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential anticancer properties of bisphosphonates.
    Neville-Webbe HL; Gnant M; Coleman RE
    Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor potential of bisphosphonates.
    Clézardin P
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antitumor effects of bisphosphonates.
    Clézardin P; Fournier P; Boissier S; Peyruchaud O
    Curr Med Chem; 2003 Jan; 10(2):173-80. PubMed ID: 12570716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
    Li J; Rugo HS
    Breast Dis; 2011; 33(2):83-92. PubMed ID: 22142661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D; Henschke P; Possinger K
    Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
    Aft R
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):194-205. PubMed ID: 21475125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G; Lipton A
    Semin Oncol; 2010 Oct; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
    Santini D; Vespasiani Gentilucci U; Vincenzi B; Picardi A; Vasaturo F; La Cesa A; Onori N; Scarpa S; Tonini G
    Ann Oncol; 2003 Oct; 14(10):1468-76. PubMed ID: 14504045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates in the prevention and treatment of bone metastases.
    Ramaswamy B; Shapiro CL
    Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antitumour effects of bisphosphonates in breast cancer].
    van de Ven S; Kroep JR; Hamdy NA; Sleeboom HP; Nortier HW
    Ned Tijdschr Geneeskd; 2010; 154():A1951. PubMed ID: 21083955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of bisphosphonates on breast cancer cells.
    Senaratne SG; Colston KW
    Breast Cancer Res; 2002; 4(1):18-23. PubMed ID: 11879555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
    Saba N; Khuri F
    Oncology; 2005; 68(1):10-7. PubMed ID: 15775688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential anticancer properties of bisphosphonates: insights from preclinical studies.
    Clezardin P
    Anticancer Agents Med Chem; 2012 Feb; 12(2):102-13. PubMed ID: 21864232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis.
    Green JR; Clézardin P
    Am J Clin Oncol; 2002 Dec; 25(6 Suppl 1):S3-9. PubMed ID: 12562045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates in cancer therapy.
    Green JR
    Curr Opin Oncol; 2002 Nov; 14(6):609-15. PubMed ID: 12409650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of bisphosphonates: from the laboratory to the clinic.
    Berenson JR
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):233-40. PubMed ID: 21825999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-tumour activity of bisphosphonates.
    Neville-Webbe HL; Holen I; Coleman RE
    Cancer Treat Rev; 2002 Dec; 28(6):305-19. PubMed ID: 12470981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates in breast cancer: antitumor effects.
    Aft R
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):292-9. PubMed ID: 21558988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.